pharmaphorum

DECEMBER 14, 2022

Last month we saw some movement in the pharma world, but also in some of the orbiting worlds of agencies, consultancies, and pharma investors. November saw the launch of a new private equity team in life sciences at J.P. Morgan Asset Management, dubbed Life Sciences Private Capital. New CEO joins UBC.

Life Science 98

Life Science Gene Therapy Gene Editing Gene 98

Drug Discovery World

MAY 6, 2024

Thanks to a prestigious academic legacy, Europe has long been a dominant region for life sciences. Europe is traditionally a life sciences powerhouse, with a strong tradition in pharmaceutical discovery. The oldest, still active pharmaceutical company worldwide, Merck, started life in 1668 in Darmstadt, Germany.

Drugs 59

Drugs Life Science Gene Editing Gene 59

Drug Discovery World

FEBRUARY 10, 2023

DDW Editor Reece Armstrong explores the Scandinavian drug discovery sector and speaks to key players about Sweden’s place in the market. Scandinavia represents one of the most exciting but perhaps underrepresented markets for the discovery and development of pharmaceuticals.

Life Science 52

Life Science Drugs Gene Therapy Manufacturing 52

Pharmaceutical Technology

FEBRUARY 13, 2023

Several biotech companies and researchers are now exploring medical devices and gene therapies to address not just common forms of epilepsy, but also rare conditions such as Dravet Syndrome. To tackle this, companies have developed different ways to focus on the gene.

Research 264

Research Gene Gene Therapy Genome 264

XTalks

MARCH 28, 2024

Bettica said the company’s focus is to now “make Duvyzat available as a treatment for DMD management in the US as quickly as possible.” Duvyzat will be competing with Sarepta Therapeutics’ bag of exon-skipping DMD therapies, which include Exondys 51 (eteplirsen), Vyondys (golodirsen) and Amondys (casimersen).

FDA Approval 105

FDA Approval Genetics Gene Therapy Gene 105

Drug Discovery World

OCTOBER 16, 2023

Dr Salako says there are some clear fields of work associated with different areas, which include: Hertfordshire as a cell and gene therapy hub, with a number of companies in this space clustered around Stevenage. billion in funding.

Drugs 75

Drugs Life Science Gene Therapy Genome 75

pharmaphorum

NOVEMBER 30, 2022

Veeva Systems invited pharmaphorum to attend its industry summit in Madrid this week, a huge event that gathered together over 1,000 individuals from life sciences and pharma. The question is, how can the journey there be accelerated, when on the horizon awaits a life sciences future very much immersed in speciality medicine?

Life Science 97

Life Science Pharma Companies Sales Marketing 97

Drug Discovery World

OCTOBER 4, 2022

Taking place at the ExCel in London from 4-5 October, ELRIG Drug Discovery 2022 is set to provide visitors with access to the latest trends, technologies and expertise driving the life sciences sector. . Cell and gene therapies. In 2021, levels of investment hit an all-time high at $22.7 billion, compared to $19.9

Gene Therapy 52

Gene Therapy Drugs Gene Manufacturing 52

pharmaphorum

NOVEMBER 23, 2022

Innovative offerings around market access. A director in life sciences consulting for EY, she works within the commercial space for such companies, as well as their clients. “My I’ve always worked as a consultant for pricing and access strategies for clients, helping them to get drugs to market and access patients.

Life Science 98

Life Science Marketing Medicine Production 98

XTalks

MARCH 22, 2023

In October 2022, Xtalks celebrated two decades of bringing diverse stakeholders in the life science industry together through first holding physical events, then soon after, hosting exclusively online events. And drugmakers are using their R&D expenditure to justify setting astronomically high list prices for new therapies.

Life Science 97

Life Science Drugs FDA Approval Vaccination 97

Drug Discovery World

APRIL 3, 2023

I quickly recognised the commercial value of aptamers as being able to address the gap in the market where antibodies fail to perform, and together we established the business to begin aptamer development. DS: The company now has clients across big pharma. To what do you attribute your success?

Antibody 52

Antibody Gene Therapy Gene In-Vitro 52

Pharmaceutical Technology

JANUARY 31, 2023

Inflation Reduction Act Speaking during the keynote panel “FDA & ARPA-H: Life Sciences, Biopharma & Medtech Priorities in a New Year”, Califf discussed the Inflation Reduction Act of August 2022, which aims to lower prescription drug prices. That leaves three years for pharma companies to prepare. It’s a hot area.”

Drugs 130

Drugs Regulation Gene Therapy Insulin 130

Pharmaceutical Technology

APRIL 24, 2023

Biologics are costly to produce and sell, and the more recent modalities, such as cell and gene therapies, can be difficult to manufacture. There are fewer sites for cell and gene therapies and vaccines – 90 companies with 127 facilities, as per GlobalData figures.

Contract Manufacturing 130

Contract Manufacturing Manufacturing Protein Sales 130

pharmaphorum

SEPTEMBER 17, 2021

Havas Life Medicom, ARK and Pharmadoctor top the agency charts AstraZeneca, klarify and Novartis Gene Therapies top the pharma leader board. Judges include experts from digital, creative and communications agencies, digital specialists and marketers from industry as well as healthcare professionals. Market Access.

Gene Therapy 52

Gene Therapy Allergies Gene Life Science 52

Pharmaceutical Technology

MAY 26, 2023

Tripling its production capacity, Touchlight can now manufacture 8kg plasmid DNA, a key component for mRNA gene therapies and vaccines. The British company’s expanded facilities boasts of 11 suites, including two class B filling suites with class A filling cabinets, warehousing and quality control laboratory capability.

DNA 130

DNA Manufacturing Gene Therapy Gene 130

XTalks

OCTOBER 22, 2020

The information shared between different multidisciplinary teams is critical to reducing the cost and ultimately accelerating the path of bringing a drug to market. To achieve transparency and actionability of data, pharmaceutical companies are evolving their manufacturing processes by digitalizing the data from all of their equipment.

Manufacturing 98

Manufacturing Development Production Gene Therapy 98

Delveinsight

AUGUST 4, 2021

Several therapies have been approved in the Epilepsy Market. The Epilepsy Treatment Market is dominated by antiepileptic medications (AEDs), which is the early treatment choice for almost all patients with multiple seizures. and Neurimmune are actively working in the Alzheimer’s Therapeutics Market. Parkinson’s Disease.

Marketing 98

Marketing Genetics Development Clinical Development 98

Drug Discovery World

JANUARY 26, 2023

DDW Editor Reece Armstrong takes a look at the pharmaceutical research and development market in 2023 and asks key opinion leaders what challenges and trends will emerge throughout the year. billion showed the pharma giant taking further steps into the oncology market and developing its speciality medicines vaccines portfolio.

Development 98

Development Drugs Clinical Trials Clinical Trials 98

Drug Discovery World

AUGUST 8, 2023

In the global pharmaceuticals market, India ranks third worldwide for production by volume and the domestic pharmaceutical market is expected to reach US$120-130 billion by 2030 1. A report by PWC shared that the pharmaceutical industry’s main markets are under ‘serious pressure’ 7.

Research 52

Research Drugs Genome Genomics 52

The Pharma Data

NOVEMBER 10, 2020

By employing the services of a CV, the company has access to a fully-managed and outfitted animal research facility that includes supporting services for preclinical rodent research, which gives them complete control over their studies and enables them to keep studies “in-house”. .

Marketing 52

Marketing In-Vivo Scientist Research 52